Sensus Healthcare (SRTS) Director Eric Sachetta Buys 20,633 Shares

What Happened
Eric Sachetta, a director of Sensus Healthcare, purchased a total of 20,633 shares in two open-market transactions. On 2026-08-26 he acquired 9,708 shares at $3.29 for $31,930 (reported), and on 2026-08-27 he acquired 10,925 shares at $3.18 for $34,752 (reported). The combined outlay was about $66,682. These were purchases (transaction code P), which investors often view as a more informative signal than routine sales.

Key Details

• Transaction dates and prices: 2026-08-26 — 9,708 shares @ $3.29 ($31,930); 2026-08-27 — 10,925 shares @ $3.18 ($34,752).
• Total shares acquired: 20,633; total reported cost: $66,682; average price ≈ $3.23/share.
• Transaction type: Open-market purchases (Code P).
• Shares owned after the transactions: Not listed in the supplied filing details.
• Filing date/timeliness: Form 4 filed 2026-08-28; transactions were reported within the normal Form 4 filing window (no late-filing flag provided).
• Footnotes/plan details: No 10b5-1 plan, tax withholding, or other special footnotes were indicated in the provided data.

Context
These were straightforward open-market purchases by a company director (not option exercises, gifts, or derivative transactions). While insider purchases can be interpreted as a positive signal because insiders are putting personal capital to work, they do not on their own prove future performance—consider them alongside company fundamentals and other information.